Blackstone Inc’s Axsome Therapeutics AXSM Stock Holding History

Blackstone Inc’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,500	Closed	-$4.14M	–	533
2026 Q1	$4.14M	Hold	24,500	–	–	0.02%	141
2025 Q4	$4.47M	Sell	24,500 -115,500	-83%	-$16.1M	0.02%	126
2025 Q3	$17M	Hold	140,000	–	–	0.07%	82
2025 Q2	$14.6M	Buy	+140,000	New	+$14.8M	0.06%	75

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Blackstone Inc's AXSM Position: Q2 2026 in Review

Blackstone Inc sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 24,500 shares — an estimated $4.14M sold.

Blackstone Inc first reported a position in AXSM in Q2 2025 and held it in 4 quarters. The position peaked at $17M in Q3 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Blackstone Inc reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
Blackstone Inc sold 24,500 Axsome Therapeutics shares in Q2 2026, an estimated $4.14M.
Blackstone Inc first reported a position in Axsome Therapeutics in Q2 2025 and held it in 4 quarters.
Blackstone Inc's Axsome Therapeutics position peaked at $17M in Q3 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.